2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]-

Request For Quotation
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:CD73-IN-9
CAS:2766565-88-0
Package:50mg;2785USD|100mg;3520USD|25mg;2140USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:CD73-IN-9
CAS:2766565-88-0
Package:1removed

2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- manufacturers

  • CD73-IN-9
  • CD73-IN-9 pictures
  • $2785.00
  • 2026-07-27
  • CAS:2766565-88-0
  • Purity:
  • Supply Ability: 10g
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Basic information
Product Name:2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]-
Synonyms:2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]-;CD73-IN-9
CAS:2766565-88-0
MF:C14H11F2N5O2
MW:319.27
EINECS:
Product Categories:
Mol File:2766565-88-0.mol
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Structure
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Chemical Properties
density 1.83±0.1 g/cm3(Predicted)
pka6.90±0.10(Predicted)
Safety Information
MSDS Information
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Usage And Synthesis
UsesCD73-IN-9 is a potent inhibitor of CD73. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-9 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 2)[1].
References[1] Xuejun Zhang, et al. Pyrimidinedione compound and use thereof. Patent WO2022068929A1.
2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]- Preparation Products And Raw materials
Tag:2,4(1H,3H)-Pyrimidinedione, 5-[4-[(1S,2S)-2-(difluoromethyl)cyclopropyl]imidazo[1,5-b]pyridazin-2-yl]-(2766565-88-0) Related Product Information